123 related articles for article (PubMed ID: 2789300)
1. The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations.
Sugiyama A; Kobayashi M; Tsujimoto G; Motomura S; Hashimoto K
Jpn J Pharmacol; 1989 Aug; 50(4):421-7. PubMed ID: 2789300
[TBL] [Abstract][Full Text] [Related]
2. A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release.
Manzini S; Perretti F; De Benedetti L; Pradelles P; Maggi CA; Geppetti P
Br J Pharmacol; 1989 Jun; 97(2):303-12. PubMed ID: 2474343
[TBL] [Abstract][Full Text] [Related]
3. Cardiac safety profile of sildenafil: chronotropic, inotropic and coronary vasodilator effects in the canine isolated, blood-perfused heart preparations.
Lubna NJ; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
J Toxicol Sci; 2016; 41(6):739-744. PubMed ID: 27853102
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
Takehana S; Sugiyama A; Hashimoto K
J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
[TBL] [Abstract][Full Text] [Related]
6. Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations.
Sugiyama A; Lurie KG; Efange SM; Takehana S; Hashimoto K
J Cardiovasc Pharmacol; 1999 Dec; 34(6):843-7. PubMed ID: 10598128
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of human calcitonin gene-related peptide in rabbit heart and in human mammary arteries.
Raddino R; Pelà G; Manca C; Barbagallo M; D'Aloia A; Passeri M; Visioli O
J Cardiovasc Pharmacol; 1997 Apr; 29(4):463-70. PubMed ID: 9156355
[TBL] [Abstract][Full Text] [Related]
8. Similarity and dissimilarity in mode and mechanism of action between YT-146, a selective adenosine receptor A2 agonist, and adenosine in isolated canine hearts.
Yoneyama F; Aihara K; Kogi K; Satoh K; Taira N
Tohoku J Exp Med; 1999 May; 188(1):31-45. PubMed ID: 10494898
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of calcitonin gene-related peptides I and II in man.
Franco-Cereceda A; Gennari C; Nami R; Agnusdei D; Pernow J; Lundberg JM; Fischer JA
Circ Res; 1987 Mar; 60(3):393-7. PubMed ID: 3495374
[TBL] [Abstract][Full Text] [Related]
10. Cardiac effects of clinically available Kampo medicine assessed with canine isolated, blood-perfused heart preparations.
Sugiyama A; Takahara A; Satoh Y; Yoneyama M; Saegusa Y; Hashimoto K
Jpn J Pharmacol; 2002 Mar; 88(3):307-13. PubMed ID: 11949886
[TBL] [Abstract][Full Text] [Related]
11. Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.
Sugiyama A; Yatomi Y; Takahara A; Satoh Y; Hashimoto K
Jpn J Pharmacol; 2002 Mar; 88(3):359-61. PubMed ID: 11949893
[TBL] [Abstract][Full Text] [Related]
12. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
Takahashi K; Endoh M; Taira N
J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
[TBL] [Abstract][Full Text] [Related]
13. Nonadrenergic noncholinergic innervation. Anatomic distribution of calcitonin gene-related peptide-immunoreactive tissue in the dog heart.
Ursell PC; Ren CL; Albala A; Danilo P
Circ Res; 1991 Jan; 68(1):131-40. PubMed ID: 1984857
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone.
Franco-Cereceda A
Acta Physiol Scand Suppl; 1988; 569():1-63. PubMed ID: 3266056
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin gene-related peptide: a potent modulator of coronary flow.
Ezra D; Laurindo FR; Goldstein DS; Goldstein RE; Feuerstein G
Eur J Pharmacol; 1987 May; 137(1):101-5. PubMed ID: 2440702
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic suppression of the nicotinic action of acetylcholine on the isolated, blood-perfused atrium of the dog.
Chiba S; Kimura T; Hashimoto K
Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):315-25. PubMed ID: 1161057
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart.
Asimakis GK; DiPette DJ; Conti VR; Holland OB; Zwischenberger JB
Life Sci; 1987 Aug; 41(5):597-603. PubMed ID: 3496512
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
20. Effects of potassium chloride on isolated, blood-perfused canine atrial or ventricular muscle preparations.
Chiba S
Jpn Heart J; 1977 May; 18(3):379-85. PubMed ID: 881752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
